SCHEMBL1817574

SCHEMBL1817574

CCc1cc(NC(C)=O)ccc1S(=O)(=O)Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
CDK1 P06493 1/20 0.49
HPGD P15428 1/20 0.49
RORC P51449 1/20 0.46
ATAD2 Q6PL18 1/20 0.45
CECR2 Q9BXF3 1/20 0.45
POLB P06746 4/20 0.44
RAB9A P51151 2/20 0.44
NR4A1 P22736 1/20 0.44
ENPP2 Q13822 1/20 0.43
MAOA P21397 2/20 0.43
MAPT P10636 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1817861 0.88 ALDH1A1 (0.48) ALDH1A1CDK1HPGDRORCATAD2
SCHEMBL539699 0.81 ALDH1A1 (0.73) ALDH1A1CDK1ATAD2CECR2RAB9A
SCHEMBL686781 0.79 ALDH1A1 (0.54) ALDH1A1CDK1ATAD2CECR2RAB9A
SCHEMBL6770516 0.79 ALDH1A1 (0.54) ALDH1A1CDK1ATAD2CECR2RAB9A
SCHEMBL3026745 0.78 HSD17B10 (0.53) ALDH1A1HPGDRORCPOLBRAB9A
SCHEMBL6771522 0.78 ALDH1A1 (0.59) ALDH1A1CDK1ATAD2CECR2POLB
SCHEMBL10719928 0.78 ATAD2 (0.65) ALDH1A1CDK1RORCATAD2CECR2
SCHEMBL14368008 0.77 RORC (0.58) RORCATAD2CECR2POLBRAB9A
SCHEMBL2436014 0.77 RORC (0.66) ALDH1A1CDK1RORCPOLBMAPT
SCHEMBL16371264 0.76 ALDH1A1 (0.40) ALDH1A1HPGDPOLBMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461134-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-07-14 US disclosed
WO-2011060196-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2011-05-19 WO disclosed
US-7579378-B2 Sulfonamido compounds that antagonize the vanilloid TRPV1 receptor PHARMESTE S.R.L. (IT) 2009-08-25 US disclosed
US-20090118374-A1 SULFONAMIDO COMPOUNDS THAT ANTAGONISE THE VANILLOID TRPV1 RECEPTOR PHARMESTE S.R.L. (IT) 2009-05-07 US disclosed
EP-1805138-B1 SULFONAMIDO COMPOUNDS THAT ANTAGONISE THE VANILLOID TRPV1 RECEPTOR PHARMESTE SRL (IT) 2008-03-19 EP disclosed
US-5516906-A Process for the preparation of N-[2-[4-(aminosulfonyl) phenyl]ethyl]5-methylpyrazinecarboxamide USV LIMITED (IN) 1996-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172187-A1 BORON-CONTAINING SMALL MOLECULES BCL6B, BCL6, BTD ALDH1A1 4190/4885CDK1 2617/4885HPGD 4100/4885
US-20090118374-A1 SULFONAMIDO COMPOUNDS THAT ANTAGONISE THE VANILLOID TRPV1 RECEPTOR TRPV1, TRPA1, TRPV4 ALDH1A1 1697/4885CDK1 1827/4885HPGD 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.